International Clinical Trial: Safety Confirmation Test through Continuous Intake of Test Food -Randomized, placebo-controlled, double-blind, parallel-group comparative trial-

Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (JPRN-UMIN000059320) titled 'Safety Confirmation Test through Continuous Intake of Test Food -Randomized, placebo-controlled, double-blind, parallel-group comparative trial-' on Oct. 7.

Study Type: Interventional

Study Design: Parallel Randomized

Primary Sponsor: TES Holdings Co., Ltd.

Condition: No

Intervention: Oral intake of the test food (1 bottle in a day 4 weeks). Oral intake of the placebo food (1 bottle in a day

Recruitment Status: Not Recruiting

Phase: Not selected

Date of First Enrollment: 2025/10/18

Target Sample Size: 40

Countries of Recruitment: Japan

To know more, visit https://center6.umin.ac.jp/cgi-open-bi...